Bibliografía del artículo
1. Colombo AL, Guimarães T. Epidemiololy of hematogenous infections due to Candida spp. Rev Soc Bras Med Trop 36(5):599-607, 2003.
2. Colombo AL, Nucci M, Park BJ, e col. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. JCM 44:2816-2823, 2006.
3. França JCB, Ribeiro CEL, Queiroz-Telles F. Candidemia em hospital terciário brasileiro: incidência, freqüência das diferentes espécies, fatores de risco e susceptibilidade aos antifúngicos. Rev Soc Bras Med Trop 41:23-28, 2008.
4. Gudlaugson O, Gillespie SH, Lee K, e col. Attributable mortality of nosocomial candidemia. Clin Infect Dis 37:1172-7, 2003.
5. Hinrichsen SL, Falcão E, Vilella TAS, e col. Candidemia em hospital terciário do nordeste do Brasil. Rev Soc Bras Med Trop 41(4):394-8, 2008.
6. Morgan J. Global trends in candidemia: review of reports form 1995-2005. Clin Infect Dis 7:429-39, 2005.
7. Nucci M, Colombo A, Silveira F, e col. Risk factors for death in patients with candidemia. Infect Control Hosp Epidemiol 19(11):846-50, 1998.
8. Aquino VR, Lunardi LW, Goldani LZ, Barth AL. Prevalence, susceptibility profile for fluconazol and risk factors for candidemia in a tertiary care hospital in southern Brazil. Braz J Infect Dis 9(5):411-8, 2005.
9. Colombo AL, Malta D, Almeida LP, Rosas R. Fluconazole susceptibility of Brazilian Candida isolates assessed by a disk diffusion method. Braz J Infect Dis 6(3):118-23, 2002.
10. Hinrichsen SL, Falcão E, Vilella TAS, e col. Candida isolates in tertiary hospitals in northeastern Brazil. BJM 40:325-28, 2009.
11. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24.179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309-17, 2004.
12. Durussel C, Nougier L, Bossy G, Parreno D, Zambardi G, Bille J. Evaluation of the new ATB FUNGUS 2 (bioMérieux) system in comparison with reference methods (NCCLS M27-A2, EUCAST) for the in vitro antifungal susceptibility testing of yeasts. Poster 302. In: Réunion Interdisciplinaire de Chimiothérapie Anti-infectieuse (RICAI), December 04-05, Paris, France, 2003.
13. Torres-Rodriguez JM, Alvarado- Ramírez E. In vitro susceptibilities to yeasts using the ATB® FUNGUS 2 method, compared with Sensititre Yeast One® and standard CLSI (NCCLS) M27-A2 methods. J Antimicrob Chemother 60(3):658-61, 2007.
14. Edmond MB, Wallace SE, Mc Clish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239-244, 1999.
15. Karlowsky JA, Zhanel GG, Klym KA, Hoban DJ, Kabani AM. Candidemia in a Canadian tertiary care hospital from 1976 to 1996. Diagn Microbiol Infect Dis 29(1):5-9, 1997.
16. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial bloodstream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 31:327-32, 1998.
17. Hinrichsen SL. Princípios da administração de qualidade e o controle de infecções. Gerenciamento de riscos. Prática Hospitalar 60:57-63, 2008.
18. Pappas PG, Kauffman CA, Andes D, e col. Clinical practice guidelines for management of candidiasis: 2009 Update by the infectious disease society of America. Treatment guidelines for candidiasis. Clin Infect Dis 48:503-35, 2009.
19. Blumberg HM, Jarvis WR, Soucie JM. Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Clin Infect Dis 33:177-186, 2001.
20. Leon C, Ruiz-Santana S, Saavedra P, e col. A bedside scoring system ("Candida score") for early antfungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34(3):730-37, 2006.
21. Schuster MG, Edwards JE, Sobel JD, e col. Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. Ann Intern Med 149:83-90, 2008.
22. Gafter-Gvili A, Vidal L, Goldberg E, Leibovici L, Paul M. Treatment of invasive candidal infections: systematic review and meta-analysis. Mayo Clin Proc 83(9):1011-21, 2008.
23. Nucci M, Perfect JR. When primary antifungal therapy fails. Clin Infect Dis 46:1426-33, 2008.
24. Colombo AL, Thompson L, Graybill JR. The north and south of candidemia: issues for Latin America. Drugs of Today 44(Suppl.A):1-34, 2008.